ArticleMolecular cancer therapeutics2022

Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246-Sensitive Disease Subtype.

Anna N Cvrljevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.